The First Affiliated Hospital of Zhejiang University — Hangzhou, Zhejiang

Public research footprint of The First Affiliated Hospital of Zhejiang University, compiled from the ClinicalTrials.gov public registry.

228

Registered studies

102

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Locally Advanced Unresectable Gastroesophageal Junction (GEJ)… · Relapsed or Refractory Mantle Cell Lymphoma (MCL) · Alzheimer Disease

Recently updated registry entries

NCT06901531 — A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With… (Recruiting)
NCT05531565 — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of… (Active Not Recruiting)
NCT04656652 — Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The First Affiliated Hospital of Zhejiang University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.